HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.
https://www.blogtalkradio.com/myelomacrowdradio
Gesamtlänge aller Episoden: 14 days 8 hours 1 minute
Myeloma Crowd Radio: Dr. Don Benson, Ohio State University
Checkpoint inhibitors are the next big thing in myeloma treatment. Learn more about how they'll be used.
Myeloma Crowd Radio: ICER President Steven D. Pearson, MD, MSc
What does the ICER report mean for payer coverage of multiple myeloma? Hear from Dr. Steven Pearson of ICER to learn more
Myeloma Crowd Radio: ICER President Steven D. Pearson, MD, MSc
What does the ICER report mean for payer coverage of multiple myeloma? Hear from Dr. Steven Pearson of ICER to learn more
Myeloma Crowd Radio: Dr. Jacob Laubach, MD, MPP, Dana Farber Cancer Institute
The Evolving Role of Proteasome Inhibitors in Multiple Myeloma
Myeloma Crowd Radio: Dr. Jacob Laubach, MD, MPP, Dana Farber Cancer Institute
The Evolving Role of Proteasome Inhibitors in Multiple Myeloma
Myeloma Crowd Radio: Dr. William Matsui, MD, Johns Hopkins Kimmel Cancer Center
Targeting pre-cursor myeloma stem cells with a new immunotherapy
Myeloma Crowd Radio: Dr. William Matsui, MD, Johns Hopkins Kimmel Cancer Center
Targeting pre-cursor myeloma stem cells with a new immunotherapy
Myeloma Crowd Radio: Melanie House, DPT, NCS, University of Iowa
How to manage physically before, during and after multiple myeloma therapy: Advice from a physical therapist
Myeloma Crowd Radio: Melanie House, DPT, NCS, University of Iowa
How to manage physically before, during and after multiple myeloma therapy: Advice from a physical therapist
Myeloma Crowd Radio: Dr. David Siegel, MD, PhD, John Theurer Cancer Center
Learn how myeloma experts like Dr. David Siegel are identifying working treatments for relapsed myeloma